Children born to mothers who contracted COVID-19 during pregnancy face a 29% higher likelihood of developmental disorders by ...

Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced incidence of ...

Children born to mothers who had COVID-19 while pregnant face an elevated risk of developmental disorders by the time they turn 3 years old, including ...

The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of ...

To read yesterday’s edition of Five things for pharma marketers to know, click here.

Q3 2025 Earnings Call Transcript October 29, 2025 OPKO Health, Inc. beats earnings expectations. Reported EPS is $0.03, ...

Moderna (NASDAQ:MRNA) stock surged as much as 12% Thursday following a STAT News report that the COVID-19 vaccine maker has been in discussions with at least one large pharmaceutical company about "a ...

Among over 800 children exposed to maternal SARS-CoV-2 infection during pregnancy, 16.3% had a neurodevelopmental diagnosis ...

Moderna is down 35.3% since the beginning of the year, and at $27.16 per share, it is trading 50.3% below its 52-week high of ...

Welcome back to Changing Faces, in our final round-up for August and September there are plenty of Board appointments to ...